Skip to main content
. Author manuscript; available in PMC: 2019 Jul 1.
Published in final edited form as: J Clin Lipidol. 2018 Apr 30;12(4):1072–1082. doi: 10.1016/j.jacl.2018.04.013

Figure 5.

Figure 5

Baseline and end-of-treatment HDL particle size distribution in all study subjects classified by treatment group. No differences across groups were observed for extra small HDL particle fraction (xs-HDL-Pima) (A), but a significant treatment effect was seen for small HDL particles (s-HDL-Pima) (B) with a significant decrease in small HDL particle fraction in the Low T/E group. No differences across groups were evident for medium HDL particle fraction (m-HDL-Pima) (C), but change in the fraction of large HDL particles (l-HDL-Pima) did differ across groups, with a significant decrease in large HDL particle fraction among subjects in the Normal E/Low E group. Data are presented as a % of total HDL particle concentration (total HDL-Pima). Whiskers = minimum to maximum values. *p<0.05 for within-group change